This cohort study conducted by the Intensive Medicines Monitoring Programme (IMMP) in New Zealand, set out to determine more accurately the rates of nocturnal enuresis in patients on clozapine and other atypical antipsychotics (olanzapine, quetiapine and risperidone). Prescription data for clozapine, olanzapine, risperidone and quetiapine were returned from pharmacies throughout New Zealand directly to the [read the full story…]